620
Participants
Start Date
August 31, 2015
Primary Completion Date
January 26, 2017
Study Completion Date
February 2, 2017
menotropin
recombinant FSH
Bloom Reproductive Institute, Scottsdale
Fertility Treatment Center, Tempe
HRC Fertility, Encino
California Fertility Partners, Los Angeles
Colorado Center for Reproductive Medicine (CCRM), Lone Tree
Reproductive Associates of Delaware, Newark
Women's Medical Research Group, Clearwater
Fertility and IVF Center of Miami, Miami
Center for Reproductive Medicine, Orlando
The Reproductive Medicine Group, Tampa
Georgia Reproductive Specialists, Sandy Springs
Fertility Institute of Hawaii, Honolulu
Idaho Center for Reproductive Medicine, Boise
Fertility Centers of Illinois, Chicago
InVia Fertility Specialists, SC, Hoffman Estates
The Advanced IVF Institute, Naperville
Shady Grove Fertility Centers, Rockville
Shady Grove Fertility, Towson
IVF New England, Lexington
Boston IVF, Waltham
Fertility Center of Las Vegas, Las Vegas
Reproductive Medicine Associates of New Jersey, Basking Ridge
Reach, Charlotte
Carolina Conceptions, Raleigh
Abington Hospital, Jefferson Health, Abington
Main Line Fertility Center, Bryn Mawr
Coastal Fertility Specialists, Mt. Pleasant
Center for Assisted Reproduction, Bedford
Houston Fertility Institute, Houston
Center of Reproductive Medicine, Webster
Utah Fertility Center, Pleasant Grove
Reproductive Care Center, Sandy City
The Jones Institute for Reproductive Medicine, Norfolk
Virginia Center for Reproductive Medicine, Reston
Seattle Reproductive Medicine, Seattle
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY